NOW Ep115: The great rewiring of global healthcare

Loading player...
Medicine is moving into a world where software spots patterns before humans sense symptoms, and breakthrough therapies can move markets faster than earnings reports. Longevity is rising, costs are climbing, and global healthcare systems are left to wonder whether innovation will save them or bankrupt them first.

In this episode of No Ordinary Wednesday, Jeremy Maggs speaks with Dr Jimmy Muchechetere from Investec Investment Management UK to unravel the forces rewiring global healthcare, from the boom-and-bust frenzy around weight-loss drugs to AI promising to predict illness long before it strikes.

Podcast key moments:

00:00 Introduction
01:34 Are we reaching the limits of human longevity?
02:13 Are weight-loss drugs a bubble or a structural shift?
04:13 How the White House–pharma deal changes drug pricing
06:58 Who wins and loses in a world with fewer illnesses?
08:10 Why longevity is becoming a macroeconomic risk
10:28 Who holds power in an AI-driven pharmaceutical world?
12:27 How to maintain trust when AI outperforms humans in diagnostics
13:51 How AI is transforming preventative medicine
16:27 Will data expertise surpass clinical expertise?
17:35 Who is accountable when AI influences medical decisions?
18:57 Why regulation must catch up with rapid AI innovation
20:47 Will AI-driven healthcare widen inequality?
22:39 How demographics and geopolitics shape healthcare tailwinds
23:56 How leaders build conviction in a VUCA healthcare landscape
25:22 The next frontier in personalised and preventative medicine

Read more on www.investec.com/now

Hosted by seasoned broadcaster, Jeremy Maggs, the No Ordinary Wednesday podcast unpacks the latest economic, business, and political news in South Africa, with an all-star cast of investment and wealth managers, economists and financial planners from Investec. Listen in every second Wednesday for an in-depth look at what's moving markets, shaping the economy, and changing the game for your wallet and your business.
Chapters
  • 00:00 Introduction
  • 01:34 Are we reaching the limits of human longevity?
  • 02:13 Are weight-loss drugs a bubble or a structural shift?
  • 04:13 How the White House–pharma deal changes drug pricing
  • 06:58 Who wins and loses in a world with fewer illnesses?
  • 08:10 Why longevity is becoming a macroeconomic risk
  • 10:28 Who holds power in an AI-driven pharmaceutical world?
  • 12:27 How to maintain trust when AI outperforms humans in diagnostics
  • 13:51 How AI is transforming preventative medicine
  • 16:27 Will data expertise surpass clinical expertise?
  • 17:35 Who is accountable when AI influences medical decisions?
  • 18:57 Why regulation must catch up with rapid AI innovation
  • 20:47 Will AI-driven healthcare widen inequality?
  • 22:39 How demographics and geopolitics shape healthcare tailwinds
  • 23:56 How leaders build conviction in a VUCA healthcare landscape
  • 25:22 The next frontier in personalised and preventative medicine
18 Nov 2025 English South Africa Business · Investing

Other recent episodes

Everything Counts | Episode 44: What the new 2026 tax allowances mean for you?

The new tax year is here, and the 2026 Budget Speech introduced important changes that could reshape how South Africans save, invest, and plan for retirement. In this episode of Everything Counts, host Motheo Khoaripe sits down with Vumi Dludlu, Investec financial adviser, and Johan Loubser, head of adviser enablement…
23 Mar 18 min

Macro Monday Ep109: War increases inflation pressures

Central banks in the US, Eurozone and Japan all kept rates unchanged last week. But behind these decisions lie rising concerns about the impact of the Iranian War on a range of prices that have a major impact on inflation. The duration and intensity of the conflict will be key…
23 Mar 9 min

What Next? | Reclaiming the future from the algorithm

Artificial intelligence is rapidly reshaping economies, societies and power structures yet much of the conversation has swung between uncritical optimism and existential fear. In this episode of What Next? We explore how leaders can reclaim agency over the future of AI, ensuring it serves human progress rather than narrow commercial…
18 Mar 39 min

NOW Ep123: Middle East conflict | Counting the cost of disruption

Markets are sending a surprisingly calm signal in the face of escalating conflict in the Middle East. Oil prices are rising, supply chains are under pressure, and recession risks are quietly ticking higher, yet equities remain relatively steady. In the latest episode of No Ordinary Wednesday, Jeremy Maggs is joined…
17 Mar 23 min

Macro Monday Ep108: Disconnect between energy and equity markets

With uncertainty over how long, the Iranian conflict will last, it’s not just the oil market that’s been affected. Natural gas prices have risen, but so too have grain and aluminium prices, pointing to inflation pressures in the coming months. However, as Chris Holdsworth, Chief Investment Strategist, at Investec Wealth…
16 Mar 11 min